Twist Bioscience Corporation (NASDAQ: TWST) reported Q3 EPS of ($0.56), $0.08 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $118.4 million versus the consensus estimate of $114.54 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.